HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatment of chronic myelogenous leukemia with oral bis (3-mesyloxypropyl) amine p-toluenesulfonate].

AuthorsM Hirano, K Koie, R Ono, K Yamada
Journal[Rinsho ketsueki] The Japanese journal of clinical hematology (Rinsho Ketsueki) Vol. 13 Issue 6 Pg. 939-42 (Dec 1972) ISSN: 0485-1439 [Print] Japan
PMID4345976 (Publication Type: Journal Article)
Chemical References
  • Alkanesulfonates
  • Alkylating Agents
  • Tosyl Compounds
Topics
  • Administration, Oral
  • Adult
  • Alkanesulfonates (administration & dosage, adverse effects, therapeutic use)
  • Alkylating Agents (administration & dosage, adverse effects)
  • Female
  • Humans
  • Leukemia, Myeloid (drug therapy)
  • Male
  • Middle Aged
  • Tosyl Compounds (administration & dosage, adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: